Stay updated with breaking news from Matthew During. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Rating) was the recipient of a significant increase in short interest in May. As of May 31st, there was short interest totalling 414,500 shares, an increase of 28.7% from the May 15th total of 322,100 shares. Currently, 0.7% of the shares of the stock are sold short. Based on […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Rating) traded up 0.9% during mid-day trading on Wednesday . The company traded as high as $3.55 and last traded at $3.48. 53,116 shares changed hands during trading, a decline of 39% from the average session volume of 87,693 shares. The stock had previously closed at $3.45. Wall Street […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Rating)’s share price was up 0.3% during mid-day trading on Wednesday . The company traded as high as $3.65 and last traded at $3.61. Approximately 129,235 shares traded hands during mid-day trading, an increase of 68% from the average daily volume of 77,129 shares. The stock had previously closed […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Rating) was up 6.6% during trading on Wednesday . The stock traded as high as $2.96 and last traded at $2.92. Approximately 116,459 shares changed hands during mid-day trading, an increase of 74% from the average daily volume of 66,949 shares. The stock had previously closed at $2.74. Wall […]
Acerus Pharmaceuticals (OTCMKTS:ASPCF – Get Rating) and Ovid Therapeutics (NASDAQ:OVID – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Analyst Ratings This is a breakdown of current ratings […]